Experimental models of pulmonary infection

被引:36
作者
Bakker-Woudenberg, IAJM [1 ]
机构
[1] Erasmus Univ, Dept Med Microbiol & Infect Dis, NL-3000 DR Rotterdam, Netherlands
关键词
pulmonary infection; animal models; infectious diseases;
D O I
10.1016/S0167-7012(03)00118-0
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Experimental models of pulmonary infection are being discussed, focused on various aspects of good experimental design, such as choice of animal species and infecting strain, and route of infection/inoculation techniques (intranasal inoculation, aerosol inoculation, and direct instillation into the lower respiratory tract). In addition, parameters to monitor pulmonary infection are being reviewed such as general clinical signs, pulmonary-associated signs, complication of the pulmonary infection, mortality rate, and parameters after dissection of animals. Examples of pulmonary infection models caused by bacteria. fungi, viruses or parasites in experimental animals with intact or impaired host defense mechanisms are shortly summarized including key-references. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:295 / 313
页数:19
相关论文
共 184 条
[1]
DOSE-DEPENDENT ANTIFUNGAL ACTIVITY AND NEPHROTOXICITY OF AMPHOTERICIN-B COLLOIDAL DISPERSION IN EXPERIMENTAL PULMONARY ASPERGILLOSIS [J].
ALLENDE, MC ;
LEE, JW ;
FRANCIS, P ;
GARRETT, K ;
DOLLENBERG, H ;
BERENGUER, J ;
LYMAN, CA ;
PIZZO, PA ;
WALSH, TJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :518-522
[2]
Modulation of immune responses in murine pulmonary histoplasmosis [J].
Allendoerfer, R ;
Boivin, GP ;
Deepe, GS .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :905-914
[3]
ANDREWS CP, 1981, AM REV RESPIR DIS, V124, P60
[4]
Plasminogen activator production in a rat model of Pneumocystis carinii pneumonia [J].
Angelici, E ;
Contini, C ;
Spezzano, M ;
Romani, R ;
Carfagna, P ;
Serra, P ;
Canipari, R .
MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (08) :605-611
[5]
Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase [J].
Aratani, Y ;
Kura, F ;
Watanabe, H ;
Akagawa, H ;
Takano, Y ;
Suzuki, K ;
Maeda, N ;
Koyama, H .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1276-1279
[6]
ANTIPNEUMOCOCCAL ACTIVITY OF CIPROFLOXACIN, OFLOXACIN, AND TEMAFLOXACIN IN AN EXPERIMENTAL MOUSE PNEUMONIA MODEL AT VARIOUS STAGES OF THE DISEASE [J].
AZOULAYDUPUIS, E ;
BEDOS, JP ;
VALLEE, E ;
HARDY, DJ ;
SWANSON, RN ;
POCIDALO, JJ .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (02) :319-324
[7]
Ciprofloxacin in polyethylene glycol-coated liposomes:: Efficacy in rat models of acute or chronic Pseudomonas aeruginosa infection [J].
Bakker-Woudenberg, IAJM ;
ten Kate, MT ;
Guo, L ;
Working, P ;
Mouton, JW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2575-2581
[8]
THERAPEUTIC ACTIVITIES OF CEFAZOLIN, CEFOTAXIME, AND CEFTAZIDIME AGAINST EXPERIMENTALLY INDUCED KLEBSIELLA-PNEUMONIAE PNEUMONIA IN RATS [J].
BAKKERWOUDENBERG, IAJM ;
VANDENBERG, JC ;
MICHEL, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (06) :1042-1050
[9]
EFFICACY OF ANTI-MICROBIAL THERAPY IN EXPERIMENTAL RAT PNEUMONIA - EFFECTS OF IMPAIRED PHAGOCYTOSIS [J].
BAKKERWOUDENBERG, IAJM ;
JONGHOENDEROP, JYTD ;
MICHEL, MF .
INFECTION AND IMMUNITY, 1979, 25 (01) :366-375
[10]
PARAMETERS OF MYCOPLASMA-PNEUMONIAE INFECTION IN SYRIAN-HAMSTERS [J].
BARILE, MF ;
CHANDLER, DKF ;
YOSHIDA, H ;
GRABOWSKI, MW ;
HARASAWA, R ;
RAZIN, S .
INFECTION AND IMMUNITY, 1988, 56 (09) :2443-2449